Civic Intelligence

T a G Treatment Action Group Inc.

990 • Fiscal year 2020 • EIN 13-3624785

Jan 01, 2020 to Dec 31, 2020 • Filed on Oct 21, 2021

Organization ProfileWWW.TREATMENTACTIONGROUP.ORG
90 Broad Street No 2503New York, NY 10004

(212) 253-7922

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

43rd percentile

0.06x

Higher debt load relative to assets than 43% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Liabilities / Revenue

36th percentile

0.06x

Higher debt load relative to revenue than 36% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Net Margin

85th percentile

36%

Higher net margin than 85% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Top Officer Pay

85th percentile

$160,894

Higher top officer pay than 85% of similar nonprofits.

Top officer pay equals 3.4% of source-year revenue.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Source year 2020

Asset Growth

90th percentile

70%

Faster asset growth than 90% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2019 to 2020

Revenue Growth

94th percentile

116%

Faster revenue growth than 94% of similar nonprofits.

2020 filings • 501(c)3 • $1M-$5M nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets43rd percentile

Assets

Up

$4,649,413

Up $1,912,953 (+70%) from 2019

Net Assets

Up

$4,367,316

Up $1,702,821 (+64%) from 2019

Liabilities

Up

$282,097

Up $210,132 (+292%) from 2019

Revenue And Expenses
Liabilities / Revenue36th percentileNet Margin85th percentile

Revenue

Up

$4,690,654

Up $2,516,464 (+116%) from 2019

Expenses

Up

$2,987,833

Up $223,289 (+8.1%) from 2019

Net Income

Up

$1,702,821

Up $2,293,175 (+388%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth90th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$6.0M$4.0M$2.0M$0Assets 2010: $2,248,827Liabilities 2010: $2,860Net Assets 2010: $2,245,9672010Assets 2011: $2,679,042Liabilities 2011: $23,023Net Assets 2011: $2,656,0192011Assets 2012: $2,851,951Liabilities 2012: $25,636Net Assets 2012: $2,826,3152012Assets 2013: $1,880,235Liabilities 2013: $41,213Net Assets 2013: $1,839,0222013Assets 2014: $3,811,240Liabilities 2014: $30,523Net Assets 2014: $3,780,7172014Assets 2015: $3,609,971Liabilities 2015: $20,734Net Assets 2015: $3,589,2372015Assets 2016: $2,592,218Liabilities 2016: $74,083Net Assets 2016: $2,518,1352016Assets 2017: $2,575,844Liabilities 2017: $80,729Net Assets 2017: $2,495,1152017Assets 2018: $3,322,765Liabilities 2018: $67,916Net Assets 2018: $3,254,8492018Assets 2019: $2,736,460Liabilities 2019: $71,965Net Assets 2019: $2,664,4952019Assets 2020: $4,649,413Liabilities 2020: $282,097Net Assets 2020: $4,367,3162020Assets 2021: $3,776,196Liabilities 2021: $356,091Net Assets 2021: $3,420,1052021Assets 2022: $3,549,278Liabilities 2022: $931,291Net Assets 2022: $2,617,9872022Assets 2023: $4,624,032Liabilities 2023: $1,012,949Net Assets 2023: $3,611,0832023Assets 2024: $3,839,139Liabilities 2024: $745,777Net Assets 2024: $3,093,3622024

Highlighted filing

2020

Assets$4,649,413
Liabilities$282,097
Net Assets$4,367,316
Open 2020 Filing

Operations Trend

Revenue Growth94th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$6.0M$4.0M$2.0M$0-$2.0MRevenue 2010: $1,912,416Expenses 2010: $2,198,624Net Income 2010: -$286,2082010Revenue 2011: $1,886,646Expenses 2011: $1,677,094Net Income 2011: $209,5522011Revenue 2012: $2,042,960Expenses 2012: $1,872,664Net Income 2012: $170,2962012Revenue 2013: $1,458,571Expenses 2013: $2,437,127Net Income 2013: -$978,5562013Revenue 2014: $4,424,915Expenses 2014: $2,483,220Net Income 2014: $1,941,6952014Revenue 2015: $2,230,880Expenses 2015: $2,419,194Net Income 2015: -$188,3142015Revenue 2016: $1,623,672Expenses 2016: $2,690,029Net Income 2016: -$1,066,3572016Revenue 2017: $2,619,130Expenses 2017: $2,642,336Net Income 2017: -$23,2062017Revenue 2018: $1,809,214Expenses 2018: $2,510,963Net Income 2018: -$701,7492018Revenue 2019: $2,174,190Expenses 2019: $2,764,544Net Income 2019: -$590,3542019Revenue 2020: $4,690,654Expenses 2020: $2,987,833Net Income 2020: $1,702,8212020Revenue 2021: $2,714,054Expenses 2021: $3,661,265Net Income 2021: -$947,2112021Revenue 2022: $2,911,955Expenses 2022: $3,714,073Net Income 2022: -$802,1182022Revenue 2023: $4,736,176Expenses 2023: $3,743,080Net Income 2023: $993,0962023Revenue 2024: $3,574,921Expenses 2024: $4,092,642Net Income 2024: -$517,7212024

Highlighted filing

2020

Revenue$4,690,654
Expenses$2,987,833
Net Income$1,702,821
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Oct 21, 2021
Return Version
2020v4.1
Gross Receipts
$4,713,154
Mission and Program Overview

Mission

Tag works to ensure that all people with hiv, tb, or hcv receive lifesaving treatment, care, and information. Tag is science-based treatment activists working to expand and accelerate vital research and effective community engagement with research and policy institutions. Tag catalyzes open collective action by all affected communities, scientists, and policy makers to end hiv, tb, and hcv.

"treatment action group (tag) is an independent, activist, and community-based research and policy think tank committed to racial, gender, and lgbtq+ equity; social justice; and liberation, fighting to end hiv, tuberculosis (tb), and hepatitis c virus (hcv).tag catalyzes open collective action by affected communities, scientists, and policymakers to ensure that all people living with or impacted by hiv, tb, or hcv - especially communities of color and other marginalized communities experiencing inequities - receive life-saving prevention, diagnosis, treatment, care, and information.we are science-based activists working to expand and accelerate vital research and effective community engagement with research and policy institutions for an end to the hiv, tb, and hcv pandemics. "

Balance Sheet Detail
LineBeginningEndChange
Assets
Pledges and Grants Receivable$496,981$2,465,371▲ $1,968,390
Savings and Temporary Cash Investments$1,584,874$1,498,766▼ $86,108
Cash and Non-Interest-Bearing Accounts$26,032$72,598▲ $46,566
Prepaid Expenses and Deferred Charges$37,208$50,247▲ $13,039
Land, Buildings, and Equipment, Net$18,580$18,477▼ $103
Accounts Receivable$7,583$1,252▼ $6,331
Total Assets$2,736,460$4,649,413▲ $1,912,953
Other Assets Total$565,202$542,702▼ $22,500
Liabilities
Unsecured Notes Loans Payable-$214,717-
Accounts Payable and Accrued Expenses$38,603$48,767▲ $10,164
Other Liabilities$33,362$18,613▼ $14,749
Total Liabilities$71,965$282,097▲ $210,132
Net Assets / Fund Balance
Net Assets With Donor Restrictions$1,126,952$2,964,485▲ $1,837,533
Net Assets Without Donor Restrictions$1,537,543$1,402,831▼ $134,712
Total Net Assets Fund Balance$2,664,495$4,367,316▲ $1,702,821
Total Liabilities and Net Assets / Fund Balance$2,736,460$4,649,413▲ $1,912,953

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings$18,477$75,331$93,808
Other Assets Org$470,239--
Compensation and Service Providers
Top Officer Pay85th percentile

Employees

NameTitleFull / Part TimeBaseTotal
Mark HarringtonExecutive DirectorFT$160,894$160,894
Erica M LessemDeputy Executive DirectorFT$137,865$137,865

Board Members and Trustees

NameTitle
Barbara HughesPresident
Robert W LennonVice President
BOBBY MCLAIN RESIGNED FEB '20Director
David I SigalDirector
Dick DadeyDirector
Eddie PeltoDirector
Frank BuaDirector
Jameel JiwaniDirector
Jim AquinoDirector
Joy EpisallaDirector
Kevin GoetzDirector
Mrinal VikramDirector
Nick DebsDirector
Richard Lynn PhdDirector
Robert MonteleoneDirector
Roy M Gulick Md MphDirector
Laura MorrisonSecretary/treasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$4,662,239
Program Service Revenue
$25,978
Investment Income
$737
Other Revenue
$1,700
All Other Contributions
$4,412,930
Change in Net Assets
$1,702,821

Audited Revenue Reconciliation

Revenue per Audited Statements
$4,690,654
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$0
Total Revenue per Audited Statements
$4,690,654
Total Revenue per Form 990
$4,690,654
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,853,686
Other Expenses$741,839
Grants and Similar Amounts Paid$392,308
Total Fundraising Expense$151,858
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$1,022,751$207,689$36,028$1,266,468
Other Employee Benefits$256,906$50,356$13,485$320,747
Grants to Domestic Orgs$313,272--$313,272
Fees for Services Other$220,979$12,456$18,518$251,953
Occupancy$157,927$29,342$7,321$194,590
Current Officers, Directors, Trustees, and Key Employees$112,625$8,045$40,224$160,894
Payroll Taxes$84,087$16,070$5,420$105,577
Foreign Grants$79,036--$79,036
Travel$49,390$1,128$260$50,778
Office Expenses$31,475$3,221$10,569$45,265
Information Technology$21,289$1,360$1,624$24,273
Conferences and Meetings$23,659$15-$23,674
Insurance$18,928$3,517$878$23,323
Fees for Services Accounting-$23,119-$23,119
Depreciation Depletion$7,934$1,474$368$9,776
Other Expenses$60$1,854$20$1,934
Advertising$190-$454$644
Total Functional Expenses$2,475,960$360,015$151,858$2,987,833

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,987,833
Total Expenses per Audited Statements$2,987,833
Total Expenses per Form 990$2,987,833
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Prep4allBrooklyn, NY-Funds Paid Out as Fiscal Sponsor-hiv Advocacy$90,772
African American Aids Policy and Training InstituteLos Angeles, CA-Hiv Advocacy-ending the Epidemic$50,000
Partnership to End Aids Status IncCordova, TN-Hiv Advocacy-ending the Epidemic$50,000
Southeast Louisiana Area Health Education CenterNew Orleans, LA-Hiv Advocacy-ending the Epidemic$50,000
Abounding Prosperity IncDallas, TX-Hiv Advocacy-ending the Epidemic$25,000
The Translatin CoalitionLos Angeles, CA-Hic Advocacy-ending the Epidemic$25,000
Act Up New York IncNew York, NY-Funds Paid Out as Fiscal Sponsor-hiv Advocacy$22,500

International Summary

Offices
0
Employees
0
Spending
$146,762

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Sub-saharan AfricaGrantsTb Advocacy00$59,122
Sub-saharan AfricaProgram ServicesTb Advocacy - Conferences00$59,122
South AsiaGrantsTb Advocacy00$14,914
Europe (including Iceland and Greenland)Program ServicesTb - Union Conference France00$7,747
South AmericaGrantsTb Advocacy00$5,000
Europe (including Iceland & Greenland)Program ServicesHcv - Virology Education Netherlands00$472
Sub-saharan AfricaProgram ServicesHcv - Inhsu Conference00$385
Fundraising, Events, and Gaming
Fundraising activities
Yes
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Fundraising Direct Expenses$0
Fundraising Gross Income$0
Professional Fundraising Fees$0

Fundraising Events

EventGross ReceiptsGross RevenueDirect ExpensesNet Income
Riaa$170,555---
Total Events$170,555---
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent Liability$18,613
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A draft of form 990 was sent to members of the board of directors for review and approval. The audit committee reviewed the form 990 and reported to the executive committee and the board of directors before the return was filed with the irs.”

Form 990, Part VI, Section B, Line 12C

“Conflict of interest policy requires board members and key staff to complete an annual disclosure statement. The related individual will be excluded from the discussion and the voting process.”

Form 990, Part VI, Section B, Line 15

“Compensation for key employees is reviewed and approved by the executive director. Compensation for the executive director is reviewed and approved by the board of directors. This was last completed in october 2019.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents are available upon request. Annual reports are available on the organization's website.”

Filing and Contact Details

Filer

Filer Name
Tag Treatment Action Group Inc
EIN
13-3624785
Phone
2122537922
Address
90 BROAD STREET NO 2503, NEW YORK, NY 10004

Signing Officer

Name
Laura Morrison
Title
Secretary/treasurer
Phone
2122537922
Signed
2021-10-21
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Laura Morrison
Formed
1992
Legal Domicile
Ny
Voting Board Members
15
Independent Board Members
15
Employees
19
Volunteers
16

Preparer

Firm
Lutz and Carr Cpas Llp
Address
551 FIFTH AVE SUITE 400, NEW YORK, NY 10176
Preparer
Michael Wallace
Phone
2126972299
Supplemental Narrative

Financial Statement Notes

PART III, LINE 4:

“The art prints are sold as part of the ticket package for major donors of the research in action awards event and subsequently sold as individual editions.”

Raw XML AppendixShowing 400 of 747 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt038603
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt048767
IRS990/AccountsReceivableGrp/BOYAmt07583
IRS990/AccountsReceivableGrp/EOYAmt01252
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0"TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS. "
IRS990/AdvertisingGrp/FundraisingAmt0454
IRS990/AdvertisingGrp/ProgramServicesAmt0190
IRS990/AdvertisingGrp/TotalAmt0644
IRS990/AllOtherContributionsAmt04412930
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0SABRINA GUERRERO-MORRIS
IRS990/BooksInCareOfDetail/PhoneNum02122537922
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt090 BROAD STREET SUITE 2503
IRS990/BooksInCareOfDetail/USAddress/CityNm0NEW YORK
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990/BooksInCareOfDetail/USAddress/ZIPCd010004
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt026032
IRS990/CashNonInterestBearingGrp/EOYAmt072598
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd01
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt040224
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08045
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0112625
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0160894
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt015
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt023659
IRS990/ConferencesMeetingsGrp/TotalAmt023674
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContriRptFundraisingEventAmt0170555
IRS990/CostOfGoodsSoldAmt022500
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt04662239
IRS990/CYGrantsAndSimilarPaidAmt0392308
IRS990/CYInvestmentIncomeAmt0737
IRS990/CYOtherExpensesAmt0741839
IRS990/CYOtherRevenueAmt01700
IRS990/CYProgramServiceRevenueAmt025978
IRS990/CYRevenuesLessExpensesAmt01702821
IRS990/CYSalariesCompEmpBnftPaidAmt01853686
IRS990/CYTotalExpensesAmt02987833
IRS990/CYTotalFundraisingExpenseAmt0151858
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt04690654
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/FundraisingAmt0368
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt01474
IRS990/DepreciationDepletionGrp/ProgramServicesAmt07934
IRS990/DepreciationDepletionGrp/TotalAmt09776
IRS990/Desc0SEE SCHEDULE OTUBERCULOSIS (TB) PROGRAMACCORDING TO THE STOP TB PARTNERSHIP, "NINE OF THE COUNTRIES WITH THE MOST TUBERCULOSIS (TB) CASES-REPRESENTING 60% OF THE GLOBAL TB BURDEN-SAW A DRASTIC DECLINE IN DIAGNOSIS AND TREATMENT OF TB INFECTIONS IN 2020, RANGING FROM 16% - 41% (WITH AN AVERAGE OF 23%). THE DROP BROUGHT THE OVERALL NUMBER OF PEOPLE DIAGNOSED AND TREATED FOR TB IN THOSE COUNTRIES TO 2008 LEVELS, A SETBACK OF 12 YEARS. THE HEAD OF THE PARTNERSHIP SAID, "TWELVE YEARS OF IMPRESSIVE GAINS IN THE FIGHT AGAINST TB, INCLUDING IN REDUCING THE NUMBER OF PEOPLE WHO WERE MISSING FROM TB CARE, HAVE BEEN TRAGICALLY REVERSED BY ANOTHER VIRULENT RESPIRATORY INFECTION." THE REPORT NOTES, "DATA EMERGING FROM INDIA AND SOUTH AFRICA SHOWS THAT PEOPLE COINFECTED WITH TB AND COVID-19 HAVE THREE TIMES HIGHER MORTALITY THAN PEOPLE INFECTED WITH TB ALONE." STOP TB PARTNERSHIP: 12 MONTHS OF COVID-19 ELIMINATED 12 YEARS OF PROGRESS IN THE GLOBAL FIGHT AGAINST TUBERCULOSIS. 12 MONTHS OF COVID-19 ELIMINATED 12 YEARS OF PROGRESS IN THE GLOBAL FIGHT AGAINST TUBERCULOSIS - PANDEMIC RESPONSE PUSHED ASIDE TUBERCULOSIS OUTREACH AND SERVICES, RESULTING IN 20% DROP IN DIAGNOSIS AND TREATMENT WORLDWIDE, URGENT RECOVERY NEEDED. GENEVA, SWITZERLAND, 14 MARCH 2021. HTTPS://WWW.STOPTB.ORG/NEWS/STORIES/2021/NS21_011.HTML. ACCESSED 18 AUGUST 2021.THOUGH PREVENTABLE AND CURABLE, TUBERCULOSIS (TB) IS THE LEADING CAUSE OF DEATH OF PEOPLE WITH HIV, AND THE LEADING INFECTIOUS KILLER GLOBALLY. RECOGNIZING THAT MUCH MORE PROGRESS COULD BE MADE IF EXISTING TOOLS WERE FULLY IMPLEMENTED, AND THAT MORE RESEARCH IS NEEDED TO END TB, TAG'S TB PROJECT STRENGTHENS EVIDENCE-DRIVEN AND HUMAN RIGHTS-BASED ADVOCACY BOTH FOR BETTER TB RESEARCH, AND FOR HIGH-QUALITY PROGRAMS AND POLICIES WORLDWIDE, THAT MEET THE NEEDS OF AFFECTED COMMUNITIES.TAG'S TB PROJECT EDUCATES, MOBILIZES, AND EMPOWERS COMMUNITIES TO INCREASE COMMUNITY UNDERSTANDING OF TB AND TO CATALYZE ACTION TO REDUCE NEW INFECTIONS, DEATHS, AND SUFFERING FROM TB AND TB/HIV. THE PROJECT WORKS WITH COMMUNITY ADVOCATES (INCLUDING COMMUNITY ADVISORY BOARDS), RESEARCHERS, POLICY MAKERS, DEVELOPERS, AND DONORS TO ENSURE NEEDS-DRIVEN RESEARCH TO IMPROVE OPTIONS FOR TB PREVENTION, DIAGNOSIS, AND TREATMENT. THE TB PROJECT PUBLISHES AN ANNUAL REPORT ON TB RESEARCH FUNDING TRENDS, AND ADVOCATES FOR ALL GOVERNMENTS OF THE WORLD TO STEP UP AND CONTRIBUTE THEIR "FAIR SHARE" INVESTMENTS IN TB R&D.THE TB PROJECT WORKS AROUND THE WORLD TO ENSURE TRANSPARENCY AND BROAD, EQUITABLE, AFFORDABLE ACCESS TO PROVEN INTERVENTIONS, FROM EARLY IN THE RESEARCH PROCESS THROUGH REGULATORY APPROVAL TO GLOBAL AND NATIONAL GUIDELINES DEVELOPMENT AND PRODUCT PRICING. TAG'S POLICY TEAM SUPPORTS THE TB PROJECT IN EDUCATING U.S. LEGISLATORS ON TB PRIORITIES, AND LEADS DOMESTIC WORK AT THE LOCAL, STATE, AND NATIONAL LEVEL TO SUPPORT AMBITIOUS AND EVIDENCE-BASED PROGRAMMING TO END TB.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt01126952
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt02964485
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt019
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01277362
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt023119
IRS990/FeesForServicesAccountingGrp/TotalAmt023119
IRS990/FeesForServicesOtherGrp/FundraisingAmt018518
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt012456
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0220979
IRS990/FeesForServicesOtherGrp/TotalAmt0251953
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt079036
IRS990/ForeignGrantsGrp/TotalAmt079036
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt09.60
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt12.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt22.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.25
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt100.10
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt110.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt131.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt140.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt150.20
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt160.70
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1840.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd12X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd13X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd14X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd15X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd16X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt120
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt130
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt140
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt150
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt160
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt170
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt180
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA HUGHES
IRS990/Form990PartVIISectionAGrp/PersonNm1ROBERT W LENNON
IRS990/Form990PartVIISectionAGrp/PersonNm2LAURA MORRISON
IRS990/Form990PartVIISectionAGrp/PersonNm3JIM AQUINO
IRS990/Form990PartVIISectionAGrp/PersonNm4FRANK BUA
IRS990/Form990PartVIISectionAGrp/PersonNm5DICK DADEY
IRS990/Form990PartVIISectionAGrp/PersonNm6NICK DEBS
IRS990/Form990PartVIISectionAGrp/PersonNm7JOY EPISALLA
IRS990/Form990PartVIISectionAGrp/PersonNm8KEVIN GOETZ
IRS990/Form990PartVIISectionAGrp/PersonNm9ROY M GULICK MD MPH
IRS990/Form990PartVIISectionAGrp/PersonNm10JAMEEL JIWANI
IRS990/Form990PartVIISectionAGrp/PersonNm11RICHARD LYNN PHD
IRS990/Form990PartVIISectionAGrp/PersonNm12BOBBY MCLAIN RESIGNED FEB '20
IRS990/Form990PartVIISectionAGrp/PersonNm13ROBERT MONTELEONE
IRS990/Form990PartVIISectionAGrp/PersonNm14EDDIE PELTO
IRS990/Form990PartVIISectionAGrp/PersonNm15DAVID I SIGAL
IRS990/Form990PartVIISectionAGrp/PersonNm16MRINAL VIKRAM
IRS990/Form990PartVIISectionAGrp/PersonNm17MARK HARRINGTON
IRS990/Form990PartVIISectionAGrp/PersonNm18ERICA M LESSEM
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt17160894
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt18137865
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2SECRETARY/TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt13DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt14DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt15DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt16DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt17EXECUTIVE DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt18DEPUTY EXECUTIVE DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr01992
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd01
IRS990/FundraisingAmt0170555
IRS990/FundraisingDirectExpensesAmt00
IRS990/FundraisingGrossIncomeAmt00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt015
IRS990/GovernmentGrantsAmt078754
IRS990/GrantAmt079036
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0313272
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0313272
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt04713154
IRS990/GrossSalesOfInventoryAmt024200
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt015
IRS990/IndivRcvdGreaterThan100KCnt02
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt01624
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt01360
IRS990/InformationTechnologyGrp/ProgramServicesAmt021289
IRS990/InformationTechnologyGrp/TotalAmt024273
IRS990/InsuranceGrp/FundraisingAmt0878
IRS990/InsuranceGrp/ManagementAndGeneralAmt03517
IRS990/InsuranceGrp/ProgramServicesAmt018928
IRS990/InsuranceGrp/TotalAmt023323
IRS990/InvestmentIncomeGrp/ExclusionAmt0737
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0737
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt022
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt075331
IRS990/LandBldgEquipBasisNetGrp/BOYAmt018580
IRS990/LandBldgEquipBasisNetGrp/EOYAmt018477
IRS990/LandBldgEquipCostOrOtherBssAmt093808
IRS990/LegalDomicileStateCd0NY
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0" TREATMENT ACTION GROUP (TAG) IS AN INDEPENDENT, ACTIVIST, AND COMMUNITY-BASED RESEARCH AND POLICY THINK TANK COMMITTED TO RACIAL, GENDER, AND LGBTQ+ EQUITY; SOCIAL JUSTICE; AND LIBERATION, FIGHTING TO END HIV, TUBERCULOSIS (TB), AND HEPATITIS C VIRUS (HCV).TAG CATALYZES OPEN COLLECTIVE ACTION BY AFFECTED COMMUNITIES, SCIENTISTS, AND POLICYMAKERS TO ENSURE THAT ALL PEOPLE LIVING WITH OR IMPACTED BY HIV, TB, OR HCV - ESPECIALLY COMMUNITIES OF COLOR AND OTHER MARGINALIZED COMMUNITIES EXPERIENCING INEQUITIES - RECEIVE LIFE-SAVING PREVENTION, DIAGNOSIS, TREATMENT, CARE, AND INFORMATION.WE ARE SCIENCE-BASED ACTIVISTS WORKING TO EXPAND AND ACCELERATE VITAL RESEARCH AND EFFECTIVE COMMUNITY ENGAGEMENT WITH RESEARCH AND POLICY INSTITUTIONS FOR AN END TO THE HIV, TB, AND HCV PANDEMICS. "
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt02664495
IRS990/NetAssetsOrFundBalancesEOYAmt04367316
IRS990/NetIncmFromFundraisingEvtGrp/TotalRevenueColumnAmt00
IRS990/NetIncomeOrLossGrp/ExclusionAmt01700
IRS990/NetIncomeOrLossGrp/TotalRevenueColumnAmt01700
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt01537543
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt01402831
IRS990/NoncashContributionsAmt0336
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/FundraisingAmt07321
IRS990/OccupancyGrp/ManagementAndGeneralAmt029342
IRS990/OccupancyGrp/ProgramServicesAmt0157927
IRS990/OccupancyGrp/TotalAmt0194590
IRS990/OfficeExpensesGrp/FundraisingAmt010569
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt03221
IRS990/OfficeExpensesGrp/ProgramServicesAmt031475
IRS990/OfficeExpensesGrp/TotalAmt045265
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherAssetsTotalGrp/BOYAmt0565202
IRS990/OtherAssetsTotalGrp/EOYAmt0542702
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt013485
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt050356
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0256906
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0320747
IRS990/OtherExpensesGrp/Desc0PRINTING & PUBLICATIONS
IRS990/OtherExpensesGrp/Desc1DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc2FUNDRAISING EVENTS
IRS990/OtherExpensesGrp/Desc3MISCELLANEOUS
IRS990/OtherExpensesGrp/FundraisingAmt04042
IRS990/OtherExpensesGrp/FundraisingAmt10
IRS990/OtherExpensesGrp/FundraisingAmt212647
IRS990/OtherExpensesGrp/FundraisingAmt320
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0150
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt1219
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt21854
IRS990/OtherExpensesGrp/ProgramServicesAmt048392
IRS990/OtherExpensesGrp/ProgramServicesAmt127060
IRS990/OtherExpensesGrp/ProgramServicesAmt260
IRS990/OtherExpensesGrp/TotalAmt052584
IRS990/OtherExpensesGrp/TotalAmt127279
IRS990/OtherExpensesGrp/TotalAmt212647
IRS990/OtherExpensesGrp/TotalAmt31934
IRS990/OtherLiabilitiesGrp/BOYAmt033362
IRS990/OtherLiabilitiesGrp/EOYAmt018613
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt036028
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0207689
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt01022751
IRS990/OtherSalariesAndWagesGrp/TotalAmt01266468
IRS990/OwnWebsiteInd0X
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PayrollTaxesGrp/FundraisingAmt05420
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt016070
IRS990/PayrollTaxesGrp/ProgramServicesAmt084087
IRS990/PayrollTaxesGrp/TotalAmt0105577
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt0496981
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt02465371
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt037208
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt050247
IRS990/PrincipalOfficerNm0LAURA MORRISON
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0900099
IRS990/ProgramServiceRevenueGrp/Desc0OTHER PROGRAM INCOME
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt025978
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt025978
IRS990/ProgSrvcAccomActy2Grp/Desc0SEE SCHEDULE OHIV PROGRAMACCORDING TO UNAIDS, "37.7 MILLION PEOPLE GLOBALLY WERE LIVING WITH HIV IN 2020. 1.5 MILLION BECAME NEWLY INFECTED WITH HIV IN 2020. 680,000 PEOPLE DIED FROM AIDS-RELATED ILLNESSES IN 2020. 27.5 MILLION PEOPLE WERE ACCESSING ANTIRETROVIRAL THERAPY IN 2020. 79.3 MILLION PEOPLE HAVE BECOME INFECTED WITH HIV SINCE THE START OF THE EPIDEMIC. 36.3 MILLION PEOPLE HAVE DIED FROM AIDS-RELATED ILLNESSES SINCE THE START OF THE EPIDEMIC. UNAIDS, GLOBAL HIV & AIDS STATISTICS - FACT SHEET 2021. HTTPS://WWW.UNAIDS.ORG/EN/RESOURCES/FACT-SHEET. ACCESSED 18 AUGUST 2021. IN THE USA, HIV EPIDEMIOLOGY RESULTS FROM 2020 ARE NOT YET AVAILABLE; THE U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) HAS PREVIOUSLY ESTIMATED UP TO 1.2 MILLION AMERICANS ARE LIVING WITH HIV. TAG'S HIV PROJECT WORKS TO MAXIMIZE EQUITABLE, AFFORDABLE ACCESS TO THE TOOLS, SERVICES, POLICIES, AND APPROACHES TO CARE THAT WE KNOW CAN END HIV. ENDING THE EPIDEMIC (ETE) ADVOCACY IS AT THE CORE OF THE HIV PROJECT'S WORK, FROM DRIVING THE NATION'S FIRST ETE INITIATIVE IN NEW YORK TO LEADING THE ACT NOW: END AIDS COALITION'S SUPPORT FOR PARTNERS IN HEAVILY BURDENED JURISDICTIONS IN THE SOUTHERN U.S. TAG'S HIV AND POLICY TEAMS TACKLE ISSUES AROUND DRUG PRICING, FUNDING FOR EVIDENCE-BASED HIV PROGRAMMING, ACCESS TO HEALTHCARE, AND POLICIES THAT PROMOTE SAFE, INCLUSIVE ENVIRONMENTS FREE OF STIGMA AND DISCRIMINATION FOR PEOPLE TO SEEK PREVENTION AND CARE FOR HIV AND RELATED INFECTIONS, INCLUDING SEXUALLY TRANSMITTED INFECTIONS.TAG'S HIV PROJECT LEADS RESEARCH ACTIVISM AND PROMOTES COMMUNITY ENGAGEMENT TO ENSURE THAT PEOPLE LIVING WITH HIV EVERYWHERE HAVE MORE OPTIONS INCLUDING, ULTIMATELY, A SAFE AND EFFECTIVE HIV VACCINE AND A CURE THAT'S SCALABLE, AFFORDABLE, AND CAN BE USED WORLDWIDE. TAG'S HIV PROJECT RECOGNIZES THAT EVEN THE MOST EFFECTIVE EXISTING PREVENTION AND TREATMENT INTERVENTIONS HAVE SHORTCOMINGS. TO THIS END, TAG TRACKS THE ANTIRETROVIRAL, CURE, IMMUNE-BASED THERAPY, AND PREVENTION PIPELINES, AND PLAYS A VITAL LEADERSHIP ROLE IN BASIC SCIENCE, VACCINES, AND CURE ADVOCACY. OUR HIV CURE-RELATED CLINICAL TRIALS WEBSITE LISTING, UPDATED MONTHLY TO PROVIDE INFORMATION ON STUDIES AND THEIR RESULTS, IS WIDELY CITED BY RESEARCHERS AND PARTNERS IN SCIENTIFIC PAPERS AND IN CONFERENCE PRESENTATIONS. THE HIV PROJECT ALSO ADVOCATES FOR APPROPRIATE INTERVENTIONS FOR PEOPLE WHO, DESPITE HIV TREATMENT, STILL HAVE POOR IMMUNE SYSTEM RECOVERY. CENTRAL TO THIS WORK IS ENSURING LEGISLATORS AND POLICY MAKERS UNDERSTAND THE NEED FOR RESEARCH FUNDING, AND HOW IMPORTANT IT IS TO MAKE DECISIONS BASED ON SCIENTIFIC EVIDENCE.UNDER THE HIV PROJECT, TAG BEGAN WORKING ON COVID-19 IN SPRING 2020 AS THE RAGING PANDEMIC THREATENED THE WELL-BEING OF ALL HUMANS EVERYWHERE, INCLUDING THOSE LIVING WITH OR AT RISK FOR INFECTION WITH THE CORE CONDITIONS ON WHICH TAG WORKS. TAG'S PERSPECTIVE IS ROOTED IN THE LESSONS LEARNED FROM THE HIV RESEARCH RESPONSE THAT BEGAN IN THE 1980S AND 1990S AND - WITH OUR ADVOCACY AROUND LEADING HIV COINFECTIONS HEPATITIS C VIRUS (HCV) AND TUBERCULOSIS (TB) - CONTINUES TODAY. WE KNOW FROM EXPERIENCE THAT INFORMING AND ENGAGING HEALTH ADVOCATES FROM VULNERABLE AND DISPROPORTIONATELY AFFECTED COMMUNITIES IS AN ESSENTIAL PART OF A COORDINATED PUBLIC HEALTH AND RESEARCH RESPONSE TO A NOVEL INFECTIOUS DISEASE.TAG, WITH PARTNERS CREATED A DEDICATED RESOURCE HUB ON SARS-COV-2 INFECTION AND COVID-19 DISEASE, AIMING TO PROVIDE INDEPENDENT ANALYSIS AND INFORMATION RESOURCES WITH A PARTICULAR FOCUS ON THE RESEARCH PIPELINES FOR THE DIAGNOSIS, TREATMENT, AND PREVENTION OF SARS-COV-2 INFECTION AND COVID-19 DISEASE. THANKS TO AN ONGOING COLLABORATION BETWEEN TAG, THE COVID-19 PREVENTION TRIALS NETWORK (COVPN), AND THE BLACK AIDS INSTITUTE, TAG CREATED COMMUNITY ENGAGEMENT MATERIALS AND WEBINARS. TREATMENT ACTION GROUP. COVID-19 PROJECT NEWS. THIS INFORMATION IS AVAILABLE AT: HTTPS://WWW.TREATMENTACTIONGROUP.ORG/COVID-19/COVID-19-PROJECT-NEWS/. ACCESSED 18 AUGUST 202
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt0964172
IRS990/ProgSrvcAccomActy2Grp/GrantAmt0313272
IRS990/ProgSrvcAccomActy3Grp/Desc0SEE SCHEDULE OHEPATITIS C VIRUS (HCV) PROGRAMGLOBALLY, OVER 71 MILLION PEOPLE ARE ESTIMATED TO HAVE HEPATITIS C VIRUS (HCV). ACCORDING TO THE WORLD HEALTH ORGANIZATION (WHO), "FOR HEPATITIS C INFECTION, 21% OF PEOPLE ARE DIAGNOSED AND 62% OF THOSE DIAGNOSED RECEIVE TREATMENT. PRICE REDUCTIONS HAVE MADE HEPATITIS C TREATMENT AN AFFORDABLE HIGH-IMPACT INTERVENTION, BUT COVERAGE NEEDS TO INCREASE NEARLY SIXFOLD IN THE NEXT DECADE TO REACH THE 2030 TARGETS FOR ELIMINATION NEW DATA SHOW THAT 9.4 MILLION PEOPLE ARE RECEIVING TREATMENT TO CURE CHRONIC HEPATITIS C VIRUS INFECTION, AN ALMOST 10-FOLD INCREASE FROM THE BASELINE OF 1 MILLION AT THE END OF 2015. THIS SCALE-UP OF TREATMENT HAS BEEN SUFFICIENT TO REVERSE THE TREND OF INCREASING MORTALITY FROM HEPATITIS C FOR THE FIRST TIME." (WHO GLOBAL PROGRESS REPORT ON HIV, VIRAL HEPATITIS AND SEXUALLY TRANSMITTED INFECTIONS, 2021 - ACCOUNTABILITY FOR THE GLOBAL HEALTH SECTOR STRATEGIES 2016-2021: ACTIONS FOR IMPACT. HTTPS://RELIEFWEB.INT/REPORT/WORLD/GLOBAL-PROGRESS-REPORT-HIV-VIRAL-HEPATITIS-AND-SEXUALLY-TRANSMITTED-INFECTIONS-2021. THE HCV PROJECT HAS BEEN AT THE FOREFRONT OF A GLOBAL HCV EDUCATION AND ADVOCACY MOVEMENT, WORKING IN COLLABORATION WITH AFFECTED COMMUNITIES, SCIENTISTS, GOVERNMENT, AND DRUG COMPANIES TO MAKE LIFE-SAVING INFORMATION, HIGH QUALITY AND AFFORDABLE TESTING AND CURES, AND SUPPORTIVE ENVIRONMENTS FOR UNDERSERVED POPULATIONS UNIVERSALLY AVAILABLE. THIS INCLUDES TRACKING THE PIPELINE FOR HCV INNOVATIONS, INCLUDING THE LATEST PANGENOTYPIC TREATMENTS, DIAGNOSTICS, AND LONG-ACTING INJECTABLES, AND INCREASING COMMUNITIES' DIAGNOSTICS AND TREATMENT LITERACY. GLOBALLY, TAG PROVIDES TECHNICAL ASSISTANCE TO BUILD LEADERSHIP CAPACITY FOR ADVANCING NATIONAL ELIMINATION CAMPAIGNS AND AMPLIFYING COMMUNITY VOICES-ESPECIALLY THOSE OF KEY POPULATIONS SUCH AS PEOPLE WHO USE DRUGS, SEX WORKERS, PRISONERS, MIGRANTS, AND MEN WHO HAVE SEX WITH MEN-IN PLANNING AND POLICY DEVELOPMENT.TAG'S HCV PROJECT AIMS TO OVERCOME BARRIERS TO ACCESS-FROM LIMITED DONOR FUNDING FOR HCV, TO SOBRIETY AND ADHERENCE RESTRICTIONS IMPOSED BY GOVERNMENTS AND PAYERS, TO PATENT AND PRICING BARRIERS, TO LIMITED VOLUNTARY LICENSING AND DELAYS IN DRUG REGISTRATION BY ORIGINATOR COMPANIES. THE HCV PROJECT ADVOCATES FOR HARM REDUCTION AND DRUG DECRIMINALIZATION EFFORTS, INCLUDING SUPPORT FOR OVERDOSE PREVENTION AND SAFE CONSUMPTION SITES, AS INJECTION DRUG USE WITHOUT ACCESS TO SAFE MATERIALS IS A MAJOR FACTOR IN HCV TRANSMISSION.IN THE U.S., TAG'S POLICY TEAM WORKS AT THE LOCAL, STATE, AND NATIONAL LEVELS: ADVOCATING FOR VIRAL HEPATITIS FUNDING, CHAMPIONING COVERAGE FOR PEOPLE WHO USE DRUGS, INCARCERATED OR OTHERWISE MARGINALIZED PEOPLE, ENCOURAGING VOLUME-BASED PRICING DEALS FOR DAAS, STRENGTHENING NATIONAL SURVEILLANCE AND SUPPORTING COMMUNITY ENGAGEMENT. TAG'S ADVOCACY HELPED ADVANCE COVERAGE FOR UNIVERSAL ADULT HCV SCREENING AND DRIVE NEW YORK STATE'S COMMITMENT TO ELIMINATE HCV-THE FIRST IN THE NATION!-WITH TAG PARTICIPATING IN THE RESULTANT STATEWIDE HCV ELIMINATION TASK FORCE.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0234426
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02144930
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0135985
IRS990/PYInvestmentIncomeAmt01347
IRS990/PYOtherExpensesAmt0987420
IRS990/PYOtherRevenueAmt0500
IRS990/PYProgramServiceRevenueAmt027413
IRS990/PYRevenuesLessExpensesAmt0-590354
IRS990/PYSalariesCompEmpBnftPaidAmt01641139
IRS990/PYTotalExpensesAmt02764544
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02174190
IRS990/QuidProQuoContributionsInd01
IRS990/QuidProQuoContriDisclInd01
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt01702821
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd01
IRS990/ReportOtherLiabilitiesInd01
IRS990/ReportProgramRelatedInvstInd00
IRS990/RevenueAmt025978
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01584874
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01498766
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt04662239
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02144930
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01781719
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt04077414
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01611085
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt014277387
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0737
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt01347
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt01668
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt01549
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01885

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$4,649,413
Liabilities
$282,097
Net assets
$4,367,316
Revenue
$4,690,654
Expenses
$2,987,833
Net income
$1,702,821
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.84$0.75$3.09$3.57$4.09$0.52
2023Detailed filing. Detailed filing data is available for this year.$4.62$1.01$3.61$4.74$3.74$0.99
2022Detailed filing. Detailed filing data is available for this year.$3.55$0.93$2.62$2.91$3.71$0.80
2021Detailed filing. Detailed filing data is available for this year.$3.78$0.36$3.42$2.71$3.66$0.95
2020Detailed filing. Detailed filing data is available for this year.$4.65$0.28$4.37$4.69$2.99$1.70
2019Detailed filing. Detailed filing data is available for this year.$2.74$0.07$2.66$2.17$2.76$0.59
2018Detailed filing. Detailed filing data is available for this year.$3.32$0.07$3.25$1.81$2.51$0.70
2017Detailed filing. Detailed filing data is available for this year.$2.58$0.08$2.50$2.62$2.64$0.02
2016Detailed filing. Detailed filing data is available for this year.$2.59$0.07$2.52$1.62$2.69$1.07
2015Detailed filing. Detailed filing data is available for this year.$3.61$0.02$3.59$2.23$2.42$0.19
2014Detailed filing. Detailed filing data is available for this year.$3.81$0.03$3.78$4.42$2.48$1.94
2013Detailed filing. Detailed filing data is available for this year.$1.88$0.04$1.84$1.46$2.44$0.98
2012Summary only. Only limited summary data is available for this year.$2.85$0.03$2.83$2.04$1.87$0.17
2011Summary only. Only limited summary data is available for this year.$2.68$0.02$2.66$1.89$1.68$0.21
2010Summary only. Only limited summary data is available for this year.$2.25$0.00$2.25$1.91$2.20$0.29